NEW YORK, May 30, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The Pharmaceutical Market: France
http://www.reportlinker.com/p0203056/The-Pharmaceutical-Market-France.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 1
Snapshot: Strategic Espicom Analysis 2
Snapshot: Key Data Projections 3
MACROENVIRONMENT 4
POLITICAL 4
ECONOMIC 5
LEGAL 6
EU Patent Protection & Intellectual Property Rights 6
Proposal for Unitary Patent 6
EU Supplementary Protection Certificates 6
EU Data Exclusivity 6
DEMOGRAPHIC 7
Projections 7
Demographic Indicators 8
Birth Rate 8
Death Rate 8
Infant Mortality 8
Life Expectancy at Birth 8
EPIDEMIOLOGY 9
DISEASE BURDEN 9
DISEASE PREVALENCE 9
Communicable Diseases 9
HIV/AIDS 9
Non-communicable Diseases 10
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 12
EU DIRECTIVE 12
Cross-Border Healthcare Directive 12
ORGANISATION 12
SHI 13
VHI 13
CMU-C 13
CNSA 14
EXPENDITURE 14
Projections 14
Latest Figures 15
Pharmaceutical Expenditure 15
INFRASTRUCTURE 16
Public Hospitals16
Ambulatory Care 16
SERVICES 17
Inpatient Analysis17
Ambulatory Activity 18
WORKFORCE 19
Projections 19
Latest Figures 20
REGULATORY AFFAIRS 21
EU REGULATORY AUTHORITY 21
NATIONAL AUTHORITY 21
MARKETING REGISTRATION 22
EU Marketing Registration22
Centralised Procedure 22
National Procedures 22
Marketing Authorisations 23
POST-MARKETING SURVEILLANCE 24
ADVERTISING 24
PRICING & REIMBURSEMENT 25
EU NETWORKING MEETING 25
NM CAPR25
PRICING 25
Pricing Activity 26
REIMBURSEMENT 26
DISTRIBUTION CHANNELS 27
EU DIRECTIVE 27
Falsified Medicines Directive 27
WHOLESALING 27
Trade Association 27
CSRP 27
Distributors 27
Alliance Healthcare27
CERP 27
OCP 28
Phoenix Pharma 28
RETAILING 28
MARKET ANALYSIS 29
SIZE 29
Projections 29
Historical Figures 31
Current Structure 32
PRODUCT DEVELOPMENT 34
EU Programmes34
Horizon 2020 34
IMI 34
Trade Association35
ARIIS 35
R&D Expenditure 36
R&D Employees 36
Companies Specialising in R&D 37
Ipsen 37
Pierre Fabre 37
Roche 37
Sanofi38
Servier 38
MANUFACTURING 39
TRADE 40
Exports 40
Imports 43
Balance of Trade 47
COMPETITION 48
TRADE ASSOCIATIONS 48
LEEM 48
LIR 48
COMPANY INTELLIGENCE 49
Local Manufacturers 49
Ipsen 49
Pierre Fabre 49
Sanofi50
Servier 51
Multinational Manufacturers 51
AstraZeneca 51
Bristol-Myers Squibb52
Eli Lilly 52
GSK 52
MSD52
Pfizer 52
Competitive Strategies53
GLOBAL COMPANY INTELLIGENCE 54
Sanofi 54
Company Overview 54
Financial Performance55
Product Portfolio 56
R&D Strategy 58
Manufacturing Capabilities 59
Outlook 59
OTC PHARMACEUTICALS 60
MARKET SIZE 60
COMPETITION 61
Trade Association61
AFIPA 61
GENERIC PHARMACEUTICALS 62
REGULATION 62
EU Marketing Registration 62
PRICING & REIMBURSEMENT 62
Pricing 62
Generic Substitution 62
MARKET SIZE 63
COMPETITION 65
Trade Association 65
GEMME 65
BIOLOGICS & BIOSIMILARS 66
REGULATION 66
EU Approval Process 66
EU Regulation of Biosimilars 66
EMA Guideline Documents67
Draft Biosimilar Concept Paper 67
Biosimilar mAb Guideline 67
Biosimilars Approved in the EU 67
National Regulation 68
French Biomedicine Agency 68
COMPETITION 68
Trade Associations 68
Atlantic Biotherapies68
Eurobiomed 68
France Biotech 68
Company Intelligence 69
AB Science 69
Carmat 69
Cellectis 69
Cerenis Therapeutics69
Exonhit 69
Genethon 69
Genfit69
GenOway 70
Hybrigenics 70
Innate Pharma 70
Ipsogen 70
LFB 70
Neovacs 71
NicOx71
Sanofi Pasteur71
Stallergenes 71
Transgene 72
Vivalis 72
Competitive Strategies 73
CONCLUSIONS: OPPORTUNITIES & CHALLENGES 74
Strategic Espicom Analysis 74
MACROENVIRONMENT 74
EPIDEMIOLOGY 74
HEALTHCARE 74
REGULATORY AFFAIRS 75
PRICING & REIMBURSEMENT75
DISTRIBUTION CHANNELS 76
COMPETITION 77
OTC PHARMACEUTICALS 77
GENERIC PHARMACEUTICALS 77
BIOLOGICS & BIOSIMILARS 77
Radar Analysis 79
SWOT Analysis 79
DIRECTORY 80
GOVERNMENT ORGANISATIONS 80
DISTRIBUTORS 80
Leading Wholesalers 80
PRODUCERS 80
Local Producers80
Multinational Producers 80
Biologic Producers 80
TRADE ASSOCIATIONS 81
List of Tables
Espicom Analysis of the Pharmaceutical Market, 2012 2
Key Data Projections, 2012-2017 3
Political Landscape, 2012 4
Regional Ranking of Projected Economies, 2017 5
Projected Economy, 2012-2017 5
Regional Ranking of Projected Demographics, 2017 7
Projected Demographics, 2012-2017 7
Principal Demographic Indicators, 2005-2011 8
New Cases of Long-Term Illnesses, 2004-2008 10
Projected Patients Registered with Long-Term Illnesses, Régime Génerale, 2008/2011/2015 11
Regional Ranking of Projected Health Expenditure, 2017 14
Projected Health Expenditure, 2012-2017 14
Health Expenditure and Medical Consumption, 2005-2010 15
Pharmaceutical Expenditure by Source of Funding, 2005-2010 (Euro Millions) 15
Hospital Activity, 2005-2009 17
Hospital Activity in Short-Stay Units, 2009 17
Diagnostic & Therapeutic Procedures Performed in Public & Private Hospitals, 2009 18
Regional Ranking of Projected Physicians, 2017 19
Projected Physicians, 2012-2017 19
Medical Personnel, 2005-2010 20
MA Activity, 2002-2010 23
Drug Pricing Applications Submitted by Type, 2010 26
Reimbursement Rates by SMR (%) 26
Regional Ranking of Projected Pharmaceutical Markets at Retail Prices, 2017 29
Projected Pharmaceutical Market at Retail Prices, 2012-2017 29
Historical Pharmaceutical Market at Retail Prices, 1995-2011 31
Pharmaceutical Sales at Manufacturers' Prices, 2000-2010 (Euro Millions) 32
Pharmaceutical Sales at Manufacturers' Prices, 2000-2010 (%) 33
Change in Pharmaceutical Sales at Manufacturers' Prices, 2001-2010 (%) 33
Reimbursable Medicine Sales in Community Pharmacies & Average Markups, 2004-2010 34
Members of ARIIS, 2012 35
Pharmaceutical Industry R&D Expenditure, 2004-2008 (Euro Millions) 36
Production of Medicaments & Vaccines for Human Use, 2004-2008 (Euro Millions) 39
Pharmaceutical Production, 1995-2010 (Euros 000s) 39
Pharmaceutical Exports by Category, 1995-2010 (US$000s)40
Pharmaceutical Exports by Country/Region, 2010 (US$000s) 42
Pharmaceutical Imports by Category, 1995-2010 (US$000s) 43
Imports of Raw Materials by Country/Region, 2010 (US$000s) 45
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 45
Imports of Medicaments by Country/Region, 2010 (US$000s) 46
Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 47
Members of LIR, 2012 48
Sanofi's Principal Operating Results, 2006-2010 (Million euros) 55
Sanofi's Revenue by Business Area, 2006-2010 (Million euros) 55
Sanofi's Revenue by Geographic Area, 2006-2010 (Million euros) 56
Sanofi's Pharmaceutical Sales by Leading Products, 2006-2010 (Million euros) 56
Sanofi's Vaccine Sales by Leading Products, 2006-2010 (Million euros) 57
Sanofi's Recent Product Approvals, 2010-2011 57
Sanofi's Major Manufacturing Facilities by Location, 2011 59
OTC Sales by Product Group at Retail Prices, 2008-2010 (Euro Millions)60
Pharmaceutical Members of AFIPA, 2012 61 Generic Sales Value & Volume in Reimbursable Pharmacy Sector at Manufacturers' Prices, 2000-2010 (%) 63
Generic Sales Value in Reimbursable Pharmacy Sector at Manufacturers' Prices, 2000-2010 64
Members of GEMME, 2012 65
Biosimilars Approved in the EU 67
Sanofi Pasteur's Sales by Vaccine Type, First Half 2009-2010 (Million Euros) 71
Espicom Analysis of the Pharmaceutical Market, 2012 78
SWOT Analysis of the Pharmaceutical Market, 2012 79
List of Charts
Regional Comparison of Top-5 Projected Pharmaceutical Markets at Retail Prices, 2017 30
Regional Comparison of Projected Pharmaceutical Market Share, 2017 30
Historical Pharmaceutical Market at Retail Prices, 1995-2011 32
Number of R&D Employees in the Pharmaceutical Industry, 1995-2008 36
Pharmaceutical Exports, 1995-2010 (US$ Billions) 41
Pharmaceutical Exports by Country/Region, 2010 (%) 41
Pharmaceutical Imports, 1995-2010 (US$ Billions) 43
Imports of Pharmaceuticals by Country/Region, 2010 (%) 44
Balance of Pharmaceutical Trade, 1995-2010 (US$ Billions) 47
Radar Graph of the Pharmaceutical Market, 2012 79
To order this report:
Pharmaceutical Industry: The Pharmaceutical Market: France
Check our Industry Analysis and Insights
__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article